Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis

por Ghannoum, M., Long, L., Larkin, E. L., Isham, N., Sherif, R., Borroto-Esoda, K., Barat, S., Angulo, D.
Publicado 2018

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

por Sobel, R, Nyirjesy, P, Ghannoum, MA, Delchev, DA, Azie, NE, Angulo, D, Harriott, IA, Borroto‐Esoda, K, Sobel, JD
Publicado 2021